… chronic kidney disease (CKD), and to evaluate the association of FGF-23, elastase, lactoferrin,
MPR, and angiogenin with arterial stiffness … AS in patients with earlystage ADPKD or late-…

… at an early stage even in the absence of traditional cardiovascular … a treatment group that
received the phosphate binder lanthanum … the effects of bisphosphonate treatment on vascular …

… established procalcifying effects in CKD, phosphate drives a … possibly combining vitamin
K2 with a phosphate binder. … hyperfunction occurring at an early stage of hyperphosphatemia. …

… treatments led to increased phosphate clearance per week and resulted in a decrease in the
use of phosphate binders … shown to help preserve kidney function, this effect could be due …

… in chronic kidney disease (CKD) patients, phosphate lowering agents might provide beneficial
effects … Phosphate lowering agents include phosphate binders (PBs), blockers of intestinal …

… but not yet proven to be a cause-effect [28, 29] and some opinions still … phosphate diet
showed that aortic medial calcification could be blocked by treatment with the phosphate binder…

… This is commonly seen in the chronic kidney disease (CKD) … both dietary phosphorus
restriction and phosphorus binders is … topic of vascular calcification and serum phosphorus needs …

… is an early-stage contributor to atheroma formation [40]. … therapies have a significant impact
on clinical outcomes [119]. The … Non-calcium-based phosphate binders such as sevelamer …

… is evident at an early stage in CKD patients, and the prevalence … effect on stroke and no
apparent effect on kidney failure … comparing four phosphate binders in predialysis CKD patients […

… Phosphate Binder in CKD Trial was to evaluate the effect of sevelamer carbonate on serum
C-terminal fibroblast growth factor 23 levels in normophosphatemic patients … kidney disease …